跳至主要内容
临床试验/NCT00003291
NCT00003291已完成不适用

Molecular Genetic Lesions and Clinical Outcome in Pediatric ALL Patients

Children's Oncology Group1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 1998年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
200
试验地点
1

研究概览

简要总结

RATIONALE: The identification of gene mutations may allow doctors to better determine the prognosis of children with acute lymphoblastic leukemia.

PURPOSE: This clinical trial is studying gene mutations to see if they are related to prognosis of cancer in children with acute lymphoblastic leukemia.

详细描述

OBJECTIVES:

  • Examine the prognostic significance of deletion of the p16 (MTS1, CDKN21) gene in children with acute lymphoblastic leukemia.
  • Attempt to correlate the incidence of specific, nonrandom combinations of molecular genetic lesions with clinical outcome in these patients.

OUTLINE: Patients are stratified by risk (standard vs high).

Bone marrow specimens from patients enrolled in CCG-1922, CCG-1882, or CCG-1901 are analyzed for the following genetic lesions: p16 deletion, p14 deletion, and p15 deletion.

Patients do not receive the results of the genetic testing and the results do not influence the type or duration of treatment.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
— 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究者

申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Molecular Genetic Lesions and Clinical Outcomes in... | 临床试验